Sign Up
Stories
Positive Results for Supira Medical and Magenta Medical's Percutaneous Ventricular Assist Devices
Share
Cordis and Boston Scientific: Advancemen...
FDA Breakthrough Device Designation for ...
Innovative Cardiac Support Devices Recei...
AI-Powered Raspberry Pi Stethoscope Inno...
Advanced Technology Saves Patient's Life
Attune Medical's Growth in Esophageal Te...
Overview
API
Supira Medical and Magenta Medical have both received positive results from their respective studies on percutaneous ventricular assist devices. Supira Medical's Supira System received FDA breakthrough device designation and closed a $40M Series D financing round. Magenta Medical's Elevate System demonstrated the feasibility and safety of providing temporary mechanical circulatory support during high-risk PCI procedures.
Ask a question
How does Supira Medical's Supira System differ from other percutaneous ventricular assist devices?
What are the key findings from Magenta Medical's Early Feasibility Study of the Elevate System?
What are the potential implications of Supira Medical's breakthrough device designation?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Coverage
stree